Impaired cholinergic dilator response of resistance arteries isolated from patients with Raynaud's disease

British Journal of Clinical Pharmacology

Volumn 47, Issue 5, 1999, Pages 507-513

  Smith, Paula J W ^a   Ferro, Charles J ^a   McQueen, Daniel S ^a   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cooling; Endothelium; Human; Nitric oxide; Raynaud's disease; Resistance arteries

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM;

ADULT; ARTERIAL PRESSURE; ARTERIOGRAPHY; ARTERY CATHETERIZATION; ARTERY DILATATION; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOLING; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; ARTERIES; COLD; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROPRUSSIDE; RAYNAUD DISEASE; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0032923519     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00958.x     Document Type: Article

References (29)

1. Dowd P. Raynaud's phenomenon. Lancet 1995; 346: 283-290.
2. Raynaud M. De l'asphyxie locale et de la gangrene symétrique des extremities. These de Paris, Library Editor: Leclerc L, 1862.
3. Miller D, Waters DD, Wamica W, Stachcic J, Kreeft J, Theroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N EnglJ Med 1981; 30: 736-738.
4. O'Keeffe ST, Tsapatsaris NP, Dcctham WP. Increased prevalence of migraine and chest pain in patients with primary Raynaud's disease. Ann lut Mcd 1992; 116: 985-989.
5. Zahavi I, Chagnac A, Mcring R, Davidovich S, Kuritzky A. Prevalence of Raynaud's phenomenon in patients with migraine. Arch Intern Med 1984; 144: 742-744.
6. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 33: 411-415.
7. Furchgott RF, Zawadzki, JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature 1980; 228: 373-376.
8. Palmer RMJ, Fertige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derivcd relaxing factor. Nature 1987; 327: 524-526.
9. Bedarida GV, Kirn D, Dlaschke TF, Huffman, DD. Vcnodilation in Raynaud's disease. Lancet 1993; 342: 1451-1454.
10. Singh S, De Trafford JC, Daskerville PA, Martin JF. Response of digital arteries to endothelium dependent and independent vasodilators in patients with Raynaud's phenomenon. EurJ Clin Invest 1995; 25: 182-185.
11. Khan F, Coffman JD. Enhanced cholinergic cutaneous vasodilatation in Raynaud's phenomenon. Circulation 1994; 89: 1183-1188.
12. Chowienczyk PJ, Cockcroft JR, Ritter JM. Differential inhibition by N -monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm. BrJ Phannacol 1993; 110: 736-738.
13. Monge L, Garcia-Villalon AL, Montoya JJ, Garcia JL, Gomez D, Dieguez G. Response of rabbit car artery to endothelin-1 during cooling. BrJ Phannacol 1991; 104: 609-612.
14. Alien EV, Brown GE. Raynaud's disease: a critical review of the minimal requisites for diagnosis. AmJ Med 1932; 183: 187-200.
15. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neural aminé uptake, and depressed excitationcontraction coupling in isolated resistance vessels from essential hypertensives. Cue Res 1987; 61: 181-186.
16. Laing RJ, Jakubowski J, Morice AH. An 111 vitro study of the pharmacological responses of rat middle cerebral artery: effects of overnight storage. J Vase Res 1995; 32: 230-236.
17. Falloon DJ, Bund SJ, Tulip JR, Heagerty AM. In vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension 1993; 22: 486-495.
18. Vanhouttc, PM.Physical factors of regulation. In Handbook of Pliysiology, Section 2, Circulation, Vol II, Vascular Smooth Muscle, (eds Bohr DF, Somlyo AP, Sparks HV, Bethesda, Maryland: Am Physiol Soc.), 1980: 443-474.
19. Aronstam RS, Narayanan TK. Temperature effect on the detection of muscarinic receptor-G protein interactions in ligand binding assays. Biochein Pliannacol 1988; 37: 1045-1049.
20. Vanhoutte PM, Shepherd JT. Effect of temperature on reactivity of isolated cutaneous veins of the dog. Am J Physiol 1970; 218: 187-190.
21. Soares de Moura R, Vanhoutte PM. Effect of cooling and wanning on the vasodilator response of the isolated dog saphenous artery to acctylcholinc. Brazilian J Mcd Biol Res 1988; 21: 157-159.
22. Moncada S, Gryglewski RJ, Bunting S, et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-667.
23. Garland CJ, Plane F, Keinp BK, Cocks TM. Endotheliumdependent hypcrpolarization: a role in the control of vascular tone. Trends Pliannacol Sei 1995; 16: 23-30.
24. Deng L-Y, Li J-S, Shiffrin EL. Endothclium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sei 1995; 88: 611-622.
25. James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Endothelial function in subcutaneous resistance arteries from elderly hypertensive and normotensive subjects. Clin Sei 1997; 92: 139-145.
26. Gardner-Medwin JM, CockcroftJR, Macdonald IA, Rowell RJ. Reduced nitric oxide-dependent vasodilatation in primary Raynaud's phenomenon. BrJ Clin Pliannacol 1996; 42: 650P-651P.
27. Khan F, Litchfield SJ, McLaren M, VealeDJ, Littleford RC, Belch JJF. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arth Rliewn 1997; 40: 352-357.
28. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-590.
29. Smith PJW, Ferro CJ, McQucen DS, Webb DJ. Functional studies in small arteries do not support a primary role for endothelin in the pathogenesis of Raynaud's disease. J Cardiovasc Pliannacol 1998; 31 Suppl. 1: S473-S476.